pindolol has been researched along with Osteosarcoma in 3 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, HY | 1 |
| Liao, JF | 1 |
| Malbon, CC | 1 |
| Pimm, MV | 1 |
| Imai, Y | 1 |
| Rodan, SB | 1 |
| Rodan, GA | 1 |
3 other studies available for pindolol and Osteosarcoma
| Article | Year |
|---|---|
Agonist regulation of beta-adrenergic receptors: immunoblotting and indirect immunofluorescence reveal agonist-induced lateral sequestration and loss of binding.
Topics: Adrenergic beta-Agonists; Animals; Bone Neoplasms; Cell Membrane; Centrifugation, Density Gradient; | 1996 |
An examination of the influence of vasoactive drugs on blood flow and localisation of a monoclonal antibody in human tumour xenografts.
Topics: Animals; Antibodies, Monoclonal; Humans; Mice; Mice, Nude; Neoplasms; Osteosarcoma; Pindolol; Propra | 1990 |
Effects of retinoic acid on alkaline phosphatase messenger ribonucleic acid, catecholamine receptors, and G proteins in ROS 17/2.8 cells.
Topics: Adenylyl Cyclases; Alkaline Phosphatase; Animals; Cell Division; Cholera Toxin; Cyclic AMP; Diphther | 1988 |